midazolam has been researched along with Pharyngitis in 3 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Pharyngitis: Inflammation of the throat (PHARYNX).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adverse events, oxygen saturation, and vital signs were recorded." | 2.80 | Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers. ( Bancke, LL; Dworak, HA; Gidal, BE; Halvorsen, MB; Rodvold, KA, 2015) |
| "Although the incidence of respiratory depression was higher in patients receiving deep sedation with propofol than in patients who were lightly sedated (17." | 1.32 | Use of deep intravenous sedation with propofol and the laryngeal mask airway during transesophageal echocardiography. ( Arens, J; Ferson, D; Sapire, K; Sinha, A; Swafford, J; Thakar, D, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bancke, LL | 1 |
| Dworak, HA | 1 |
| Rodvold, KA | 1 |
| Halvorsen, MB | 1 |
| Gidal, BE | 1 |
| Ferson, D | 1 |
| Thakar, D | 1 |
| Swafford, J | 1 |
| Sinha, A | 1 |
| Sapire, K | 1 |
| Arens, J | 1 |
| Cierpka, K | 1 |
| Rickenbacher, P | 1 |
| Burckhardt, D | 1 |
| Lüscher, TF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Supraglottic Airway Use for Transesophageal Echocardiography: a Safe Alternative to Deep Sedation for Patients With High-risk Cardiopulmonary Disease. (SGA-TEE)[NCT04939220] | 110 participants (Anticipated) | Interventional | 2024-02-29 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for midazolam and Pharyngitis
| Article | Year |
|---|---|
Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
Topics: Administration, Intranasal; Adolescent; Adult; Chemistry, Pharmaceutical; Cross-Over Studies; Dose-R | 2015 |
2 other studies available for midazolam and Pharyngitis
| Article | Year |
|---|---|
Use of deep intravenous sedation with propofol and the laryngeal mask airway during transesophageal echocardiography.
Topics: Adult; Aged; Airway Obstruction; Anesthesiology; Anesthetics, Intravenous; Cardiology; Drug Therapy, | 2003 |
[Subjective tolerance to transesophageal echocardiography].
Topics: Adult; Age Factors; Aged; Deglutition Disorders; Echocardiography, Transesophageal; Female; Hiccup; | 1994 |